Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 10 studies | 22% ± 11% | |
intestine | 8 studies | 31% ± 15% | |
lung | 7 studies | 35% ± 15% | |
placenta | 5 studies | 28% ± 15% | |
uterus | 4 studies | 33% ± 15% | |
breast | 4 studies | 28% ± 12% | |
pancreas | 3 studies | 27% ± 5% | |
kidney | 3 studies | 24% ± 8% | |
bone marrow | 3 studies | 19% ± 1% | |
lymph node | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 22788.46 | 180 / 180 | 100% | 116.06 | 430 / 430 |
pancreas | 100% | 13263.99 | 328 / 328 | 100% | 87.05 | 178 / 178 |
prostate | 100% | 7917.56 | 245 / 245 | 100% | 183.79 | 502 / 502 |
thymus | 100% | 6335.93 | 653 / 653 | 100% | 109.37 | 605 / 605 |
esophagus | 100% | 7894.31 | 1444 / 1445 | 100% | 65.63 | 183 / 183 |
skin | 100% | 13533.27 | 1807 / 1809 | 100% | 148.56 | 472 / 472 |
bladder | 100% | 9016.24 | 21 / 21 | 100% | 131.38 | 503 / 504 |
breast | 100% | 8921.64 | 459 / 459 | 100% | 132.31 | 1115 / 1118 |
stomach | 100% | 5608.09 | 359 / 359 | 100% | 112.11 | 285 / 286 |
uterus | 100% | 10818.28 | 170 / 170 | 100% | 118.17 | 457 / 459 |
intestine | 100% | 7183.81 | 966 / 966 | 99% | 145.37 | 524 / 527 |
lung | 100% | 6609.84 | 576 / 578 | 100% | 79.97 | 1152 / 1155 |
kidney | 100% | 4853.03 | 89 / 89 | 98% | 57.80 | 882 / 901 |
brain | 93% | 2614.46 | 2444 / 2642 | 100% | 103.87 | 704 / 705 |
adrenal gland | 100% | 6464.10 | 258 / 258 | 92% | 45.89 | 211 / 230 |
liver | 86% | 2462.07 | 194 / 226 | 95% | 55.95 | 384 / 406 |
adipose | 100% | 8182.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 205.33 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 169.60 | 29 / 29 |
muscle | 100% | 10871.76 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5285.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 103.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 100.28 | 1 / 1 |
blood vessel | 100% | 5330.17 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 3359.93 | 802 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 4863.46 | 652 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097294 | Biological process | 'de novo' XMP biosynthetic process |
GO_0071353 | Biological process | cellular response to interleukin-4 |
GO_0046651 | Biological process | lymphocyte proliferation |
GO_0007623 | Biological process | circadian rhythm |
GO_0006177 | Biological process | GMP biosynthetic process |
GO_0006183 | Biological process | GTP biosynthetic process |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003938 | Molecular function | IMP dehydrogenase activity |
GO_0000166 | Molecular function | nucleotide binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IMPDH2 |
Protein name | IMP dehydrogenase (EC 1.1.1.205) Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205) Inosine monophosphate dehydrogenase 2 Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (Inosine-5'-monophosphate dehydrogenase type II) (IMP dehydrogenase II) (IMPDH-II) Inosine monophosphate dehydrogenase type II |
Synonyms | IMPDH IMPD2 |
Description | FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth . Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism . It may also have a role in the development of malignancy and the growth progression of some tumors. . FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. . FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. . FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. . FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. . |
Accessions | ENST00000678724.1 P12268 ENST00000326739.9 A0A7I2V2T3 A0A7I2V337 ENST00000429182.6 Q6RUP8 A0A7I2YQK5 Q6QE17 A0A7I2V5N6 ENST00000677010.1 ENST00000679117.1 ENST00000442157.2 Q6RUP9 E7ETK5 ENST00000677480.1 H0Y4R1 |